Novartis (NVS) Financial Analysis & Valuation | Quarter Chart
Novartis (NVS)
NVSPrice: $157.59
Fair Value: 🔒
🔒score
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology,... more
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The compa... more
Description
Shares
| Market Cap | $300.70B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | CH | CEO | Vas Narasimhan |
| IPO Date | 1996-11-07 | CAGR | 0.03% |
| Employees | 75,511 | Website | www.novartis.com |
| Div. Yield | 2.9% | Payout Ratio | 0.61% |
| Buy Back Yield | 2.78% | Total Yield | 5.68% |
NVS chart loading...
Fundamentals
Technicals
| Enterprise Value | $342.37B | P/E Ratio | 18.13 |
| Forward P/E | 15.92 | PEG Ratio | -2.43 |
| P/S Ratio | 5.65 | P/B Ratio | 8.12 |
| P/CF Ratio | 16.51 | P/FCF Ratio | 18.85 |
| EPS | $8.69 | EPS Growth 1Y | 9.23% |
| EPS Growth 3Y | 114.77% | EPS Growth 5Y | 100.57% |
| Revenue Growth 1Y | 5.32% | Gross Margin | 0.75% |
| Operating Margin | 0.3% | Profit Margin | 0.24% |
| ROE | 0.32% | ROA | 0.11% |
| ROCE | 0.19% | Current Ratio | 0.85 |
| Quick Ratio | 0.65 | Cash Ratio | 0.22 |
| Debt/Equity | 1.22 | Interest Coverage | 13.57 |
| Altman Z Score | 3.6 | Piotroski Score | 6 |